área de pesquisa FISIOLOGIA E FARMACOLOGIA CARDIOVASCULAR Isabella Bonilha de Oliveira Kadmiel Candido Chagas Rationale and design of the expanded combination of evolocumab plus empagliflozin in diabetes: EXCEED-BHS3 trial
